CoChat

Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease

Open access
AbdAlla, Said, Lother, Heinz, el Missiry, Ahmed, Langer, Andreas, Sergeev, Pavel, el Faramawy, Yasser, Quitterer, Ursula · 2009 · Journal of Biological Chemistry
Cited by 89

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Progressive neurodegeneration and decline of cognitive functions are major hallmarks of Alzheimer disease (AD). Neurodegeneration in AD correlates with dysfunction of diverse signal transduction mechanisms, such as the G-protein-stimulated phosphoinositide hydrolysis mediated by Gαq/11. We report here that impaired Gαq/11-stimulated signaling in brains of AD patients and mice correlated with the appearance of cross-linked oligomeric angiotensin II AT2 receptors sequestering Gαq/11. Amyloid β (Aβ) was causal to AT2 oligomerization, because cerebral microinjection of Aβ triggered AT2 oligomerization in the hippocampus of mice in a dose-dependent manner. Aβ induced AT2 oligomerization by a two-step process of oxidative and transglutaminase-dependent cross-linking. The induction of AT2 oligomers in a transgenic mouse model with AD-like symptoms was associated with Gαq/11 dysfunction and enhanced neurodegeneration. Vice versa, stereotactic inhibition of AT2 oligomers by RNA interference prevented the impairment of Gαq/11 and delayed Tau phosphorylation. Thus, Aβ induces the formation of cross-linked AT2 oligomers that contribute to the dysfunction of Gαq/11 in an animal model of Alzheimer disease. Progressive neurodegeneration and decline of cognitive functions are major hallmarks of Alzheimer disease (AD). Neurodegeneration in AD correlates with dysfunction of diverse signal transduction mechanisms, such as the G-protein-stimulated phosphoinositide hydrolysis mediated by Gαq/11. We report here that impaired Gαq/11-stimulated signaling in brains of AD patients and mice correlated with the appearance of cross-linked oligomeric angiotensin II AT2 receptors sequestering Gαq/11. Amyloid β (Aβ) was causal to AT2 oligomerization, because cerebral microinjection of Aβ triggered AT2 oligomerization in the hippocampus of mice in a dose-dependent manner. Aβ induced AT2 oligomerization by a two-step process of oxidative and transglutaminase-dependent cross-linking. The induction of AT2 oligomers in a transgenic mouse model with AD-like symptoms was associated with Gαq/11 dysfunction and enhanced neurodegeneration. Vice versa, stereotactic inhibition of AT2 oligomers by RNA interference prevented the impairment of Gαq/11 and delayed Tau phosphorylation. Thus, Aβ induces the formation of cross-linked AT2 oligomers that contribute to the dysfunction of Gαq/11 in an animal model of Alzheimer disease. Alzheimer disease (AD) 2The abbreviations used are: AD, Alzheimer disease; Aβ, amyloid β; APPSw mice, transgenic mice expressing human APP695 with the double mutation (K670N/M671L) that was identified in a Swedish family with early onset Alzheimer disease; GTPγS, guanosine 5′-O-(thiotriphosphate); CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; HA, hemagglutinin; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; HEK, human embryonic kidney; RNAi, RNA interference. is a protein aggregation disease that is characterized by profound neuropathological changes in the brain, including neurodegeneration, neurofibrillary tangles, and the accumulation of fibrillar β-amyloid (Aβ) in extracellular senile plaques. Although some neuropathological features of AD, such as tangles and plaques, are also detected in brains of elderly people without major symptoms of dementia (1Price J.L. Morris J.C. Ann. Neurol. 1999; 45: 358-368Crossref PubMed Scopus (1387) Google Scholar), neurodegeneration and neuronal loss of AD patients are associated with the major AD symptoms of memory impairment and dementia (2Gomez-Isla T. Hollister R. West H. Mui S. Growdon J.H. Petersen R.C. Parisi J.E. Hyman B.T. Ann. Neurol. 1997; 41: 17-24Crossref PubMed Scopus (1139) Google Scholar, 3Price J.L. Ko A.I. Wade M.J. Tsou S.K. McKeel D.W. Morris J.C. Arch. Neurol. 2001; 58: 1395-1402Crossref PubMed Scopus (464) Google Scholar). Neurodegeneration in AD is accompanied by dysfunction of diverse signal transduction mechanisms, such as the G-protein-stimulated phosphoinositide hydrolysis mediated by Gαq/11 (4Ferrari-DiLeo G. Flynn D.D. Life Sci. 1993; 53: PL439-PL444Crossref PubMed Scopus (58) Google Scholar, 5Fowler C.J. Cowburn R.F. Garlind A. Winblad B. O'Neill C. Mol. Cell Biochem. 1995; 149: 287-292Crossref PubMed Scopus (33) Google Scholar, 6Greenwood A.F. Powers R.E. Jope R.S. Neuroscience. 1995; 69: 125-138Crossref PubMed Scopus (73) Google Scholar, 7Jope R.S. Song L. Li X. Powers R. Neurobiol. Aging. 1994; 15: 221-226Crossref PubMed Scopus (78) Google Scholar, 8Tsang S.W. Lai M.K. Kirvell S. Francis P.T. Esiri M.M. Hope T. Chen C.P. Wong P.T. Neurobiol. Aging. 2006; 27: 1216-1223Crossref PubMed Scopus (83) Google Scholar). Gαq/11-stimulated signal transduction pathways are important for neuronal communication, synaptic plasticity, and neuronal survival (9Miura M. Watanabe M. Offermanns S. Simon M.I. Kano M. J. Neurosci. 2002; 22: 8379-8390Crossref PubMed Google Scholar, 10Wettschureck N. van der Stelt M. Tsubokawa H. Kr

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m807746200

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
AbdAlla, S., Lother, H., el Missiry, A., Langer, A., Sergeev, P., el Faramawy, Y., & Quitterer, U.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2009-03
Volume
284
Issue
10
Pages
6554-6565
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1982516779
Cited by
89
References
8
FWCI
6.03
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.